Akimov Y, Aittokallio T(2021) Re-defining synthetic lethality by phenotypic profiling for precision oncology Cell Chem Biol(in press) DOI 10.1016/j.chembiol.2021.01.026, PubMed 33631125
Ianevski A, Lahtela J, Javarappa KK, Sergeev P, Ghimire BR, Gautam P, Vähä-Koskela M, Turunen L, Linnavirta N, Kuusanmäki H, Kontro M, Porkka K, Heckman CA, Mattila P, Wennerberg K, Giri AK, Aittokallio T(2021) Patient-tailored design for selective co-inhibition of leukemic cell subpopulations Sci Adv, 7(8) DOI 10.1126/sciadv.abe4038, PubMed 33608276
Tanoli Z, Vähä-Koskela M, Aittokallio T(2021) Artificial intelligence, machine learning, and drug repurposing in cancer Expert Opin Drug Discov, 1-13(in press) DOI 10.1080/17460441.2021.1883585, PubMed 33543671